A randomized double-blind, placebo-controlled study of two intravenous dosing regimens of h5G1.1-scFc in patients with acute myocardial infarction undergoing percutaneous transluminal coronary angioplasty reperfusion therapy,
Role: Investigator,
Procter & Gamble Company,
Status: Completed
A randomized, double-blind, placebo-controlled study of two intravenous dosing regimens of h5G1.1scFv in patients with acute myocardial infarction undergoing thrombolytic reperfusion therapy,
Role: Investigator,
Procter & Gamble Company,
Status: Completed
Internal
An observational study - timing of hospital discharge after antibiotics are changed from intravenous to oral; same day versus next day. A risk benefit analysis.,
Role: Investigator,
Loma Linda University Medical Center,
(06/1999 - 05/2000)
Status: Completed
Non-Profit Organization
Cholesterol and recurrent events (CARE): an inter-continental secondary prevention trial of lowering blood cholesterol after myocardial infarction,
Role: Investigator,
Bristol-Myers Squibb Foundation, Inc.,
(05/1997 - 05/1998)
Status: Completed